ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Endometrial Cancer
Recurrence
Adenocarcinoma

Prostate Cancer trials near Boston, MA, USA:

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

(ADT) in the treatment of metastatic, non-metastatic, and advanced prostate cancers. The first phase of the study is to establish a...

Active, not recruiting
Metastatic Prostate Cancer
Non-metastatic Prostate Cancer
Drug: GNRH-A Goserelin
Drug: Abemaciclib

Phase 1, Phase 2

Praful Ravi, MB BCHir, MRCP

Boston, Massachusetts, United States

This research study is studying an immune-based cancer drug as a possible treatment for prostate cancer.The drug involved ...

Active, not recruiting
Prostate Cancer
Drug: Nivolumab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States and 4 other locations

with the radioligand treatment, 177Lu-PSMA-617, is safe in treating prostate cancer and whether the combination is effective in shr ...

Enrolling
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: 177Lu-PSMA-617
Drug: Carboplatin

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 2 other locations

improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (A...

Enrolling
Prostate Cancer Metastatic
Prostate Cancer
Other: Aerobic and resistance exercise
Other: Usual Care
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: BMS-986460

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Boston, Massachusetts, United States and 7 other locations

androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...

Active, not recruiting
Prostate Cancer
Drug: Placebo oral tablet
Drug: Luteinizing Hormone-Releasing Hormone Analog

Phase 3

University of Sydney

Boston, Massachusetts, United States and 92 other locations

pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007

Phase 1

Janux Therapeutics

Providence, Rhode Island, United States and 15 other locations

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110 in Combination with Abiraterone

Phase 1

Arvinas
Arvinas

Boston, Massachusetts, United States and 17 other locations

The objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to su...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer
Radiation: Radium 223
Drug: Docetaxel

Phase 1

Tufts University
Tufts University

Boston, Massachusetts, United States and 3 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Enrolling
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

Boston, Massachusetts, United States and 22 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems